Treg Cell Therapy for Autoimmune Diseases from Japan
Regulatory T-cells (Tregs) expanded ex vivo from patient blood, modified for enhanced suppressive function, used in treating graft-versus-host disease post-transplant. HTS 3002.51.00.00 covers these as cell therapy products—biotechnologically modified cell cultures for immunotherapy. They restore immune tolerance by suppressing overactive responses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Include lot-specific potency assays and sterility test results in import documentation
• Ship under IATA dangerous goods regulations for Category A infectious substances